About Magneto Thrombectomy
Magneto Thrombectomy is a Healthcare company based in Or Yehuda (Israel) founded in 2016 by Yuval Taff. It operates as a thrombectomy solutions are developed for blood clot removal in arteries. Its chief executive is Benny Dilmoney. Magneto Thrombectomy offers products and services including Magneto Catheter, eTrieve PE Kit, and eTrieve Microcatheter. Its focus areas include Life Sciences, Hematology, Medical Devices and Surgical. Its competitors include Inari Medical, Akura Medical, Endovascular Engineering, EmerStat and Retriever Medical and 1 more; 4 of its 6 listed competitors have raised funding.
Company details
The company was founded in 2016 in Or Yehuda, Israel, and operates in the medical device sector focused on neurovascular treatments. Thrombectomy solutions are provided to address blood clots, including the Magneto eTrieve microcatheter designed for neurovascular arteries. Proximal and distal emboli can be removed with minimal arterial interaction and reduced fragmentation. Leadership includes co-founder Yuval Taff and CEO Benny Dilmoney.
Products & Services of Magneto Thrombectomy
Magneto Thrombectomy offers a comprehensive portfolio of products and services, including Magneto Catheter, eTrieve PE Kit, and eTrieve Microcatheter.
Uses electric fields to attract and remove blood clots from vessels.
Custom kit for removing clots in pulmonary arteries with aspiration.
Microcatheter for neurovascular clot removal with minimal interaction.
People of Magneto Thrombectomy
3 people are tracked at Magneto Thrombectomy (3 in leadership).
| Name | Role | Group |
|---|---|---|
Yuval Taff | Co-Founder | Leadership |
Benny Dilmoney | CEO | Leadership |
Tami Abudi | VP Clinical Affairs | Leadership |
Complete people profiles for Magneto Thrombectomy
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Magneto Thrombectomy
Magneto Thrombectomy has 6 listed competitors in our database, 4 of them funded. They include Inari Medical, Akura Medical, Endovascular Engineering, EmerStat and Retriever Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inarimedical.com | 2011 | Irvine, United States | $51.89M | 696 | Catheter-based thrombectomy devices for vascular emboli removal are developed. | |
| akuramed.com | 2021 | Campbell, United States | $60M | – | Catheter-based thrombectomy devices for thrombus removal are developed. | |
| endovascularengineering.com | 2019 | Menlo Park, United States | $42M | – | Engineering services are provided to medical device manufacturers. | |
| emerstat.com | 2022 | Singapore | – | – | Creates innovative hemostatic devices for efficient trauma care and surgical applications. | |
| rtvmed.com | 2020 | Las Vegas, United States | – | – | Provides medical devices for vascular care and clot removal treatments. | |
| nexgenmedsystem.com | 2002 | Reno, United States | $1.02M | – | Develops thrombectomy devices for the effective removal of blood clots. |
Detailed competitors of Magneto Thrombectomy
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Hematology
10 companies that operate in the same segment as Magneto Thrombectomy (Hematology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small activating RNA therapeutics are developed to restore gene function. | 2008 | London, England, United Kingdom | USD 460.41 M | USD 23.07 M | 37 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 300 M | – | 384 | |
Developer of therapeutics for the treatment of hematologic diseases | 2017 | Cambridge, Massachusetts, United States | USD 140 M | – | 84 | |
Gene therapy platform is developed for chronic disease treatments. | 2015 | Stevenage, Hertfordshire, United Kingdom | USD 273.69 M | USD 435.87 K | 152 | |
Novel anticoagulants for thrombosis treatment are developed. | 2019 | Cambridge, Massachusetts, United States | USD 250 M | – | 13 | |
Developer of therapies for treating hemochromatosis & beta thalassemia | 1989 | San Diego, California, United States | – | USD 75.72 M | 71 | |
Breakthrough therapies are developed for blood diseases and infections. | 2014 | Buffalo, New York, United States | USD 1 M | – | 22 | |
Hematology products and solutions are provided for medical applications. | 1971 | Braintree, Massachusetts, United States | – | USD 1.33 B | 3,020 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Magneto Thrombectomy
Complete news archive for Magneto Thrombectomy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Magneto Thrombectomy
Magneto Thrombectomy was founded in 2016.
Magneto Thrombectomy is headquartered in Or Yehuda, Israel.
Benny Dilmoney is the current CEO of Magneto Thrombectomy.
The company was founded in 2016 in Or Yehuda, Israel, and operates in the medical device sector focused on neurovascular treatments. Thrombectomy solutions are provided to address blood clots, including the Magneto eTrieve microcatheter designed for neurovascular arteries. Proximal and distal emboli can be removed with minimal arterial interaction and reduced fragmentation. Leadership includes co-founder Yuval Taff and CEO Benny Dilmoney.
Magneto Thrombectomy's top competitors include Inari Medical, Akura Medical and Endovascular Engineering.
Magneto Thrombectomy offers Magneto Catheter, eTrieve PE Kit, and eTrieve Microcatheter.